1. The most dangerous way to lose weight

    Rejected diet drug staging a comeback

    It's the drug that could push dieters to the brink of a heart attack -- and it may be coming soon to a pharmacy near you.

    The drug Contrave has been linked to increased blood pressure levels and pulse rates -- which is why the FDA actually REJECTED it earlier this year. (Trust me, I was as surprised as you are.)

    But when the company that makes the drug stood up to the FDA, the agency backed down. (Now THERE'S the FDA we've all come to know and hate.)

    When the feds rejected the med, they demanded a major long-term study to make sure the drug's possible heart risks wouldn't kill too many people.

    That study never happened.

    Instead, they ended up signing off on a much less ambitious two-year study that proves absolutely nothing. And you know what that means. When this drug eventually hits the market, you'll be the guinea pig that determines the real heart risks.

    And believe me, there WILL be risks: Contrave isn't just one potentially bad med. It's a two-fer -- a powerful antidepressant and a risky anti-addiction drug rolled into one. And the blood pressure and pulse problems are only the beginning.

    Patients in clinical trials suffered headaches, nausea, and more -- with one battling a gall bladder infection and another coming down with seizures. It's no wonder 40% of trial participants DROPPED OUT.

    If that's not enough to keep you away from the med, consider this: It doesn't even work!

    As little as 40 percent of the people who took it in clinical trials experienced a loss in body weight of 5 percent or more -- meaning obese people who pop these pills will become slightly less obese pill-poppers... if they manage to lose any weight at all.

    But you don't need to wait for the next risky diet drug to drop those pounds. There are safe and natural ways to get the job done right, and they start with what's on your dinner plate.

    For more on the best diets -- including the low-rated lifestyle that's moving to the top of my list -- check out the September issue of the Douglass Report.

    Not a subscriber? Sign up here -- unlike those meds, my newsletter comes with a risk-free guarantee.

  2. Double take over diet drug

    Nixed med could return from the grave

    Imagine that -- the FDA insisting on thorough research into a drug's deadliest risks BEFORE approval!

    What the heck got into them?

    The agency broke tradition earlier this year when it overruled one of its own panels and rejected Contrave, an experimental diet drug from Orexigen that's been shown to raise blood pressure and heart rates.

    Instead of the usual rubber stamp, the FDA asked the company for a new study to see if those warning signs led to real heart risk -- a simple request that sent Orexigen into a childish hissy-fit.

    "I'm taking my toys and going home," the company said in a statement.

    OK, they didn't really say that -- but they practically did: The company said that instead of conducting the FDA's study, it would take its med overseas to people who don't care about all this heart risk mumbo-jumbo.

    That'll teach us!

    The company said all that extra research would be "unprecedented and would generate significantly more information than is necessary or feasible."

    I don't know about you, but I've never heard of a drug that killed people via unnecessary information.

    They're right about one thing, though: It is unprecedented, because the FDA is usually too happy to approve meds before all the risks are known, turning patients into guinea pigs -- with deadly consequences.

    Vioxx, anyone? How about Avandia?

    I was ready to give credit where credit was due here and applaud the FDA for this rare triumph of common sense when I read a disturbing new report.

    Orexigen's CEO told Bloomberg news that the feds might be willing to overlook this safety business after all. He claims the FDA told him it would reexamine cardiovascular standards for diet drugs next year -- allowing Contrave to be "measured by a different bar."

    You can bet your bulging belly they won't be raising that bar.

2 Item(s)